Mr. Brad Sorenson at the Industry, Science and Technology Committee

Chief Executive Officer, Providence Therapeutics

The mRNA vaccines have the ability to be redosed, so they do not have that same challenge as the viral vector deliveries.

See context to find out what was said next.